Is Lasa Supergenerics a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lasa Supergenerics Ltd is a below average quality company .

Is Lasa Supergenerics undervalued or overvalued?

The key valuation ratios of Lasa Supergenerics Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Lasa Supergenerics share price return in the past 10 years?

Data is not available for this company

Is Lasa Supergenerics a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Lasa Supergenerics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Lasa Supergenerics Ltd - Stock Valuation and Financial Performance

Name: Lasa Supergenerics
Brand: Lasa Supergenerics

BSE: 540702 | NSE: LASA | Pharmaceuticals & Drugs | Small Cap

Place order

Lasa Supergenerics Share Price

₹24.94 -0.09 -0.36%
as on 19-Apr'24 14:27

10 Year X-Ray of Lasa Supergenerics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	0%	0%	0%	11.2%	9.7%	-2.9%	5.1%	13.1%	0.4%	-13.3%	-
Value Creation Index ⓘ	NA	NA	NA	-0.2	-0.3	-1.2	-0.6	-0.1	-1.0	-2.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	199	244	170	167	202	137	130	117
Sales YoY Gr.	-	NA	NA	NA	22.5%	-30.4%	-1.4%	21%	-32.2%	-5.5%	-
Adj EPS ⓘ	0	0	0	501.5	5.4	-5.2	1	5.6	0.1	-4.8	-4.3
YoY Gr.	-	NA	NA	NA	-98.9%	-196.7%	NA	475.3%	-97.9%	-4091.7%	-
BVPS (₹) ⓘ	0	0	-60.2	10,983.3	51.3	46.1	34.8	39.1	31.5	23.6	22.3
Adj Net Profit ⓘ	0	0	0	2.5	12.3	-11.9	4	22.7	0.6	-24	-21
Cash Flow from Ops. ⓘ	0	0	-0.4	-3	40.4	40.7	13.6	41.3	9.2	-17.3	-
Debt/CF from Ops. ⓘ	0	0	-1	-38.6	2.6	2.1	3.6	0.5	2.2	-1.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-11.9%	-8.2%	-5.5%
Adj EPS ⓘ	NA	-197.7%	-270.3%	-4091.7%
BVPSⓘ	NA	-14.4%	-12.1%	-25.1%
Share Price	-	1.5%	-26%	-1.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	0	6.6	12.8	-10.7	3.2	15.1	0.4	-17.4	-18.6
Op. Profit Mgn % ⓘ	0	23	16.9	6.7	18.2	23.3	12.3	-3.6	9
Net Profit Mgn % ⓘ	0	1.3	5.1	-7	2.4	11.2	0.5	-18.5	-18.4
Debt to Equity ⓘ	-1.2	2.1	0.9	0.8	0.3	0.1	0.1	0.2	-
Working Cap Days ⓘ	0	66	138	206	169	118	147	123	67
Cash Conv. Cycle ⓘ	0	27	53	39	0	18	41	33	-3

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -8.16%

Sales growth is not so good in last 4 quarters at -17.23%

Latest Financials - Lasa Supergenerics Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-4.3	-
TTM Sales (₹ Cr.)	117	-
BVPS (₹.) ⓘ	22.3	-
Reserves (₹ Cr.) ⓘ	62	-
P/BV ⓘ	1.12	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	20.10 / 40.95
All Time Low / High (₹)	9.48 / 214.90
Market Cap (₹ Cr.)	125
Equity (₹ Cr.)	50.1
Face Value (₹)	10
Industry PE ⓘ	47.6

Management X-Ray of Lasa Supergenerics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

43.23

35.15

31.19

20.66

* Pledged shares as % of Promoter's holding (%)

Valuation of Lasa Supergenerics

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Lasa Supergenerics

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	0	199	244	170	167	202	137	130
Operating Expenses ⓘ	0	153	202	159	137	155	121	136
Manufacturing Costs	0	10	14	13	16	18	12	14
Material Costs	0	131	172	128	95	112	91	106
Employee Cost	0	10	10	12	13	14	7	7
Other Costs ⓘ	0	3	7	6	13	11	10	9
Operating Profit ⓘ	0	46	41	11	30	47	16	-7
Operating Profit Margin (%)	-	22.9%	16.9%	6.5%	17.9%	23.3%	11.7%	-5.1%
Other Income ⓘ	0	2	3	1	0	0	0	2
Interest ⓘ	0	12	11	8	8	2	0	4
Depreciation ⓘ	0	8	18	19	17	16	15	13
Exceptional Items ⓘ	0	-26	0	0	0	0	-8	-20
Profit Before Tax ⓘ	0	2	15	-16	5	29	-6	-42
Tax ⓘ	0	0	3	-4	1	7	-1	-4
Profit After Tax	0	2	12	-12	4	23	-5	-39
PAT Margin (%)	-	1.2%	5.1%	-7.1%	2.2%	11.3%	-3.9%	-29.8%
Adjusted EPS (₹)	0.0	472.5	5.4	-5.3	0.9	5.6	-1.1	-7.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	4%	-23%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	0	55	117	105	141	159	158	118
Share Capital ⓘ	0	0	23	23	41	41	50	50
Reserves ⓘ	0	55	94	82	101	118	108	68
Minority Interest	0	0	0	0	0	0	0	0
Debt	0	104	90	69	34	0	0	0
Long Term Debt	0	81	60	46	14	0	0	0
Short Term Debt	0	23	30	23	20	0	0	0
Trade Payables	0	25	48	60	34	13	17	9
Others Liabilities ⓘ	0	44	31	22	19	36	34	36
Total Liabilities ⓘ	0	228	287	255	229	208	209	164
Fixed Assets
Gross Block	0	132	201	212	220	226	234	229
Accumulated Depreciation	0	13	31	50	67	83	96	110
Net Fixed Assetsⓘ	0	119	170	162	152	143	137	119
CWIP ⓘ	0	30	7	7	0	0	5	5
Investmentsⓘ	0	0	0	0	0	0	0	0
Inventories	0	33	42	32	26	17	11	14
Trade Receivables	0	35	42	29	21	15	19	2
Cash Equivalents	0	1	3	3	6	4	17	2
Others Assetsⓘ	0	10	23	23	24	28	20	21
Total Assets ⓘ	0	228	287	255	229	208	209	164

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0	-3	40	41	14	41	9	-17
PBT ⓘ	0	2	15	-16	5	29	2	-22
Adjustment ⓘ	0	17	26	27	25	18	6	-4
Changes in Working Capital ⓘ	-0	-22	1	33	-16	-6	4	9
Tax Paid ⓘ	0	0	-2	-4	0	0	-3	0
Cash Flow From Investing Activity ⓘ	0	0	-44	-7	-2	-4	-3	11
Capex	0	-2	-47	-11	-1	-7	3	5
Net Investments	0	0	-1	0	-1	3	-6	5
Others ⓘ	0	2	3	4	0	0	0	2
Cash Flow From Financing Activityⓘ	0	0	4	-33	-10	-36	0	-4
Net Proceeds from Shares ⓘ	0	0	30	0	33	0	0	0
Net Proceeds from Borrowing ⓘ	0	6	-20	-15	-32	-14	0	0
Interest Paid ⓘ	0	-12	-11	-12	-8	-2	0	-4
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	0	6	7	-7	-3	-20	0	0
Net Cash Flow ⓘ	0	-3	0	0	2	1	6	-10

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	N/A	8.65	14.33	-10.81	2.94	15.17	-3.37	-27.97
ROCE (%)	N/A	14.45	12.8	-3.73	6.77	17.14	-3.41	-23.94
Asset Turnover Ratio	0	1.91	0.95	0.63	0.69	0.93	0.66	0.69
PAT to CFO Conversion(x)	N/A	-1.5	3.33	N/A	3.5	1.78	N/A	N/A
Working Capital Days
Receivable Days	0	58	57	76	54	32	44	30
Inventory Days	0	56	56	79	63	39	38	36
Payable Days	0	35	78	153	180	75	59	45

Lasa Supergenerics Ltd Stock News

Lasa Supergenerics Ltd FAQs

What is the share price of Lasa Supergenerics?

Company share prices are keep on changing according to the market conditions. The closing price of Lasa Supergenerics on 19-Apr-2024 14:27 is ₹24.94.

What is the market cap of Lasa Supergenerics?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Apr-2024 14:27 the market cap of Lasa Supergenerics stood at ₹125.4.